Targeted discovery of gut microbiome-remodeling compounds for the treatment of systemic inflammatory response syndrome/Experiment 21/Signature 1
From BugSigDB
Needs review
Source: Figure 8C
Description: Abundance comparison of key genera between SIRS patients and healthy volunteers.
Abundance in Group 1: increased abundance in P (Patients with SIRS)
| NCBI | Quality Control | Links |
|---|---|---|
| Enterococcus | ||
| Lactobacillus | ||
| Bacteroides | ||
| Enterobacter | ||
| Lachnoclostridium | ||
| Escherichia/Shigella sp. | ||
| Akkermansia | ||
| Pseudomonas | ||
| Ralstonia | ||
| Dysgonomonas |
Revision editor(s): Ifeanyisam
